Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation play
Motilal Oswal has reiterated a “buy” rating on Glenmark Pharmaceuticals with a raised target price of Rs 2,430, implying a ...
Tag: Glenmark Pharmaceuticals
Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr
Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr - The Economic Times ...
